Phenotypic screening-the fast track to novel antibody discovery

Area of Science:

• Biotechnology
• Pharmacology
• Immunology

Background:

• Traditional target-led drug discovery for antibody therapeutics is resource-intensive.
• Identifying validated targets is increasingly challenging and competitive.
• Phenotypic drug discovery is emerging as a viable alternative strategy.

Purpose of the Study:

• To review successful antibody phenotypic screens leading to clinical drug candidates.
• To outline the requirements for effective antibody phenotypic screening.
• To discuss the future implications of phenotypic drug discovery for antibody pipelines.

Main Methods:

• Review of literature on antibody phenotypic screens.
• Analysis of case studies of successful antibody phenotypic drug discovery.
• Discussion of antibody enrichment and target identification strategies.

Main Results:

• Several successful examples of antibody phenotypic screens yielding clinical drug candidates were identified.
• Key requirements for effective antibody phenotypic screening were elucidated.
• The review highlights the growing importance and potential of phenotypic approaches.

Conclusions:

• Phenotypic drug discovery is a valuable strategy for antibody therapeutic development.
• Effective antibody enrichment and target identification are crucial for success.
• This approach is poised to significantly impact future antibody drug pipelines.